Metanephric adenoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{SC}}
{{CMG}}; {{AE}} {{SC}}
==Overview==
==Overview==
On gross pathology, a sharply circumscribed, nonencapsulated solitary [[mass]] is the characteristic finding of metanephric adenoma. On microscopic histopathological analysis, small uniform cells with fine chromatin and smooth nuclear membrane, variable architecture, and psammoma bodies are characteristic findings of metanephric adenoma.
On gross pathology, a sharply circumscribed, nonencapsulated solitary [[mass]] is the characteristic finding of metanephric adenoma. On microscopic histopathological analysis, small uniform cells with fine [[chromatin]] and smooth [[nuclear membrane]], variable architecture, and [[Psammoma body|psammoma bodies]] are characteristic findings of metanephric adenoma.


==Gross Pathology==
==Gross Pathology==
Line 15: Line 15:
* Small uniform cells with:
* Small uniform cells with:
:* Fine chromatin
:* Fine chromatin
:* No apparent nucleolus
:* No apparent [[nucleolus]]
:* Smooth nuclear membrane
:* Smooth [[nuclear membrane]]
* Variable architecture:
* Variable architecture:
:* May be sheets, ductal or micropapillary
:* May be sheets, ductal or micropapillary
* Psammoma bodies may present
* [[Psammoma body|psammoma bodies]] may present





Revision as of 13:42, 10 November 2015

Metanephric adenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Metanephric adenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Metanephric adenoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Metanephric adenoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Metanephric adenoma pathophysiology

CDC on Metanephric adenoma pathophysiology

Metanephric adenoma pathophysiology in the news

Blogs on Metanephric adenoma pathophysiology

Directions to Hospitals Treating Metanephric adenoma

Risk calculators and risk factors for Metanephric adenoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

On gross pathology, a sharply circumscribed, nonencapsulated solitary mass is the characteristic finding of metanephric adenoma. On microscopic histopathological analysis, small uniform cells with fine chromatin and smooth nuclear membrane, variable architecture, and psammoma bodies are characteristic findings of metanephric adenoma.

Gross Pathology

Characteristic findings of metanephric adenoma on gross pathology include:[1]

  • Solitary mass
  • Sharply circumscribed
  • Not encapsulated

Microscopic Pathology

The characteristics of metanephric adenomas include:[2]

  • Small uniform cells with:
  • Variable architecture:
  • May be sheets, ductal or micropapillary


Genetics

References

  1. Metanephric adenoma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Metanephric_adenoma Accessed on November 9, 2015
  2. Metanephric adenoma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Metanephric_adenoma Accessed on November 9, 2015
  3. Metanephric adenoma. Libre Pathology 2015. http://librepathology.org/wiki/index.php/Metanephric_adenoma Accessed on November 9, 2015
  4. Pesti T, Sükösd F, Jones EC, Kovacs G (2001). "Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping". Human Pathology. 32 (1): 101–4. doi:10.1053/hupa.2001.21132. PMID 11172302.

Template:WH Template:WS